{"id":10268,"date":"2010-04-02T13:54:24","date_gmt":"2010-04-02T13:54:24","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=10268"},"modified":"2013-08-07T08:45:44","modified_gmt":"2013-08-07T08:45:44","slug":"17th-conference-on-retroviruses-and-opportunistic-infections-croi","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/10268","title":{"rendered":"17th Conference on Retroviruses and Opportunistic Infections (CROI), 16-19 February 2010, San Francisco"},"content":{"rendered":"<p><strong>Introduction<\/strong><\/p>\n<p><strong>The 17th Conference on Retroviruses and Opportunistic Infections (CROI), one of the most important annual HIV meetings, was held this year from 16-19 February.\u00a0<\/strong><\/p>\n<p>As with previous meetings, much of the conference is published online including all abstracts and webcasts of oral presentations including poster discussions.<\/p>\n<p>Making this scientific content available without login or subscription is itself a significant achievement. It is a model for broadening access to medical research to a degree that is currently unmatched by any other meeting.<\/p>\n<p>The webcasts this year include oral presentations, poster discussions, the opening lectures and the pre-meeting set of training workshops for young investigators.<\/p>\n<p>The conference website also includes a searchable\u00a0abstract database.<\/p>\n<p>We encourage readers to view these lectures directly.<\/p>\n<p><a href=\"http:\/\/www.retroconference.org\/AbstractSearch\/\">http:\/\/www.retroconference.org\/AbstractSearch\/<\/a><\/p>\n<p><a href=\"http:\/\/www.retroconference.org\/2010\/data\/files\/webcast_2010.htm\">http:\/\/www.retroconference.org\/2010\/data\/files\/webcast_2010.htm<\/a><\/p>\n<p>Lectures are also available as audio downloads and podcasts which include slides as audiobooks.<\/p>\n<p>Our first articles covering this meeting are:<\/p>\n<ul>\n<li><a title=\"Permanent link to Treatment reduces infections by over 90%: a theme that is here to&lt;br \/&gt;\nstay\" href=\"https:\/\/i-base.info\/htb\/10266\" rel=\"bookmark\">Treatment reduces infections by over 90%: a theme that is here to stay<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to ACTG 5205: atazanavir\/ritonavir vs efavirenz in treatment naive patients\" rel=\"bookmark\"> href=&#8221;https:\/\/i-base.info\/htb\/10264&#8243;&gt;ACTG 5205: atazanavir\/ritonavir vs efavirenz in treatment naive patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent&lt;br \/&gt;\nlink to Pipeline compounds and new approaches to treatment\" href=\"https:\/\/i-base.info\/htb\/10262\" rel=\"bookmark\">Pipeline compounds and new approaches to<br \/>\ntreatment<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Clinical benefits of stopping smoking: CVD and CHD risk returns to that of \u0091previous smoker\u0092&lt;br \/&gt;\nin HIV-positive people within three years\" href=\"https:\/\/i-base.info\/htb\/10258\" rel=\"bookmark\">Clinical benefits of stopping smoking: CVD and CHD risk<br \/>\nreturns to that of \u0091previous smoker\u0092 in HIV-positive people within three years<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to HIV increases the risk&lt;br \/&gt;\nof lung cancer, independent of smoking status\" href=\"https:\/\/i-base.info\/htb\/10256\" rel=\"bookmark\">HIV increases the risk of lung cancer, independent of<br \/>\nsmoking status<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to HIV-positive people in the HOPS cohort have 4-fold risk of fracture compared to&lt;br \/&gt;\ngeneral population in the US\" href=\"https:\/\/i-base.info\/htb\/10254\" rel=\"bookmark\">HIV-positive people in the HOPS cohort have 4-fold risk of fracture<br \/>\ncompared to general population in the US<\/a><\/li>\n<\/ul>\n<ul>\n<li>href=&#8221;https:\/\/i-base.info\/htb\/10248&#8243;&gt;Vitamin D deficiencies in HIV management<\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to OCTANE 2: nevirapine and&lt;br \/&gt;\nlopinavir\/r are similar when used with tenofovir and FTC in treatment-naive women\" href=\"https:\/\/i-base.info\/htb\/10245\" rel=\"bookmark\">OCTANE 2: nevirapine<br \/>\nand lopinavir\/r are similar when used with tenofovir and FTC in treatment-naive women<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to HIV incidence&lt;br \/&gt;\nand retesting in pregnancy\" href=\"https:\/\/i-base.info\/htb\/10242\" rel=\"bookmark\">HIV incidence and retesting in pregnancy<\/a><\/li>\n<\/ul>\n<ul>\n<li>&lt;a<br \/>\ntitle=&#8221;Permanent link to Efavirenz use in pregnancy and birth outcomes&#8221; rel=&#8221;bookmark&#8221; href=&#8221;https:\/\/i-base.info\/htb\/10240&#8243;&gt;Efavirenz use in pregnancy and<br \/>\nbirth outcomes<\/li>\n<\/ul>\n<ul>\n<li>href=&#8221;https:\/\/i-base.info\/htb\/10238&#8243;&gt;Pregnancy outcomes in women using non-AZT HAART in Europe<\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to When&lt;br \/&gt;\nshould HAART be initiated in pregnancy to achieve an undetectable viral load?\" href=\"https:\/\/i-base.info\/htb\/10234\" rel=\"bookmark\">When should HAART be<br \/>\ninitiated in pregnancy to achieve an undetectable viral load?<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Pregnancy outcomes in infants exposed&lt;br \/&gt;\nto maternal antiretrovirals in utero\" href=\"https:\/\/i-base.info\/htb\/10232\" rel=\"bookmark\">Pregnancy outcomes in infants exposed to maternal antiretrovirals<br \/>\nin utero<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Maternal TB, HIV and pregnancy\" href=\"https:\/\/i-base.info\/htb\/10230\" rel=\"bookmark\">Maternal<br \/>\nTB, HIV and pregnancy<\/a><\/li>\n<\/ul>\n<p>More to follow next issue&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Introduction The 17th Conference on Retroviruses and Opportunistic Infections (CROI), one of the most important annual HIV meetings, was held this year from 16-19 February.\u00a0 As with previous meetings, much of the conference is published online including all abstracts and &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,64],"class_list":["post-10268","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-croi-2010"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/10268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=10268"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/10268\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=10268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=10268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=10268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}